DK98089D0 - Medikament-lipid-systemer med lav toxicitet - Google Patents

Medikament-lipid-systemer med lav toxicitet

Info

Publication number
DK98089D0
DK98089D0 DK098089A DK98089A DK98089D0 DK 98089 D0 DK98089 D0 DK 98089D0 DK 098089 A DK098089 A DK 098089A DK 98089 A DK98089 A DK 98089A DK 98089 D0 DK98089 D0 DK 98089D0
Authority
DK
Denmark
Prior art keywords
lipid
compositions
hdlcs
low toxicity
lipid complexes
Prior art date
Application number
DK098089A
Other languages
English (en)
Other versions
DK176010B1 (da
DK98089A (da
Inventor
Andrew S Janoff
Lawrence Boni
Thomas Madden
Pieter R Cullis
Robert P Lenk
John J Kearns
Anthony G Durning
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27361805&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK98089(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Publication of DK98089A publication Critical patent/DK98089A/da
Publication of DK98089D0 publication Critical patent/DK98089D0/da
Application granted granted Critical
Publication of DK176010B1 publication Critical patent/DK176010B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A61K47/544—Phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • G—PHYSICS
    • G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03B—APPARATUS OR ARRANGEMENTS FOR TAKING PHOTOGRAPHS OR FOR PROJECTING OR VIEWING THEM; APPARATUS OR ARRANGEMENTS EMPLOYING ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ACCESSORIES THEREFOR
    • G03B2227/00—Photographic printing apparatus
    • G03B2227/32—Projection printing apparatus, e.g. enlarging apparatus, copying camera
    • G03B2227/325—Microcapsule copiers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Vehicle Step Arrangements And Article Storage (AREA)
  • Catalysts (AREA)
  • Vehicle Interior And Exterior Ornaments, Soundproofing, And Insulation (AREA)
DK198900980A 1987-03-05 1989-03-01 Medikament-lipid-systemer med lav toxicitet DK176010B1 (da)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US2215787A 1987-03-05 1987-03-05
US2215787 1987-03-05
US6990887A 1987-07-06 1987-07-06
US6990887 1987-07-06
US7930987A 1987-07-29 1987-07-29
US7930987 1987-07-29
US8800647 1988-03-03
PCT/US1988/000647 WO1988006443A1 (en) 1987-03-05 1988-03-03 Low toxicity drug-lipid systems

Publications (3)

Publication Number Publication Date
DK98089A DK98089A (da) 1989-03-01
DK98089D0 true DK98089D0 (da) 1989-03-01
DK176010B1 DK176010B1 (da) 2005-11-28

Family

ID=27361805

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198900980A DK176010B1 (da) 1987-03-05 1989-03-01 Medikament-lipid-systemer med lav toxicitet

Country Status (20)

Country Link
EP (1) EP0282405B2 (da)
KR (1) KR970002870B1 (da)
CN (1) CN1044093C (da)
AT (1) ATE118169T1 (da)
AU (1) AU622405B2 (da)
CA (1) CA1338701C (da)
DE (1) DE3852961T3 (da)
DK (1) DK176010B1 (da)
ES (1) ES2070131T5 (da)
FI (1) FI102724B1 (da)
GR (1) GR3015916T3 (da)
HK (1) HK1007495A1 (da)
IE (1) IE67152B1 (da)
IL (1) IL85607A (da)
LU (1) LU88684I2 (da)
NL (1) NL990004I1 (da)
NO (4) NO179995C (da)
NZ (1) NZ223660A (da)
PT (1) PT86913B (da)
WO (1) WO1988006443A1 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5178875A (en) * 1991-01-14 1993-01-12 The Board Of Regents, The University Of Texas System Liposomal-polyene preliposomal powder and method for its preparation
US5830498A (en) * 1987-10-16 1998-11-03 Board Of Regents, The University Of Texas System Liposomal-polyene preliposomal powder and method for its preparation
AU598958B2 (en) 1987-11-12 1990-07-05 Vestar, Inc. Improved amphotericin b liposome preparation
ES2087151T3 (es) * 1989-03-31 1996-07-16 Univ California Preparacion de composiciones complejas de liposomas y lipidos.
US5188951A (en) * 1990-04-17 1993-02-23 The Liposome Company, Inc. Enzymatic synthesis of soluble phosphatides from phospholipids
DE4108903A1 (de) * 1990-08-06 1992-02-13 Nattermann A & Cie Pharmazeutisches produkt
US5556637A (en) * 1990-08-06 1996-09-17 A. Nattermann & Cie. Gmbh Water containing liposome system
EP0556392A4 (en) * 1990-11-06 1994-03-17 Nippon Shinyaku Co Ltd PROCESS FOR PRODUCING A FATTY EMULSION.
US5534502A (en) * 1990-11-06 1996-07-09 Nippon Shinyaku Co. Ltd. Process for producing fat emulsion
EP0599977A1 (en) * 1991-08-14 1994-06-08 SEQUUS PHARMACEUTICALS, INC. (a Delaware Corporation) Hiv-treatment method with low-toxicity amphotericin b
PT699068E (pt) * 1993-05-21 2002-06-28 Liposome Co Inc Reducao de reaccoes fisiologicas adversas induzidas por lipossomas
US5716526A (en) * 1994-01-14 1998-02-10 The Liposome Company, Inc. Method of separating materials from liposomes or lipid complexes
US5902604A (en) 1995-06-06 1999-05-11 Board Of Regents, The University Of Texas System Submicron liposome suspensions obtained from preliposome lyophilizates
GB2326337A (en) * 1997-06-20 1998-12-23 Phares Pharma Holland Homogeneous lipid compositions for drug delivery
US6165997A (en) * 1997-11-20 2000-12-26 Statens Serum Institut Phospholipids having antimicrobial activity with or without the presence of antimicrobials
US20070178147A1 (en) * 2005-12-08 2007-08-02 Desai Narendra R Liposomal compositions
KR101132626B1 (ko) * 2009-10-12 2012-04-02 주식회사 녹십자 난용성 약물의 전달을 위한 고밀도지단백 나노입자의 제조방법
RU2595865C2 (ru) 2010-08-20 2016-08-27 Др. Редди'З Лабораториз, Лтд. Фосфолипидный депо-препарат
WO2012054447A2 (en) 2010-10-22 2012-04-26 Dr. Reddy's Laboratories, Inc. Use of storage stable viscous phospholipid depot to treat wounds
AU2013257608B2 (en) 2012-05-10 2017-12-14 Painreform Ltd. Depot formulations of a hydrophobic active ingredient and methods for preparation thereof
WO2016205384A1 (en) 2015-06-15 2016-12-22 The University Of Washington Multiple drug lipid nanoparticle composition and related methods for extended drug levels in blood and lymph tissue

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4310506A (en) * 1979-02-22 1982-01-12 California Institute Of Technology Means of preparation and applications of liposomes containing high concentrations of entrapped ionic species
FR2521565B1 (fr) * 1982-02-17 1985-07-05 Dior Sa Parfums Christian Melange pulverulent de constituants lipidiques et de constituants hydrophobes, procede pour le preparer, phases lamellaires lipidiques hydratees et procede de fabrication, compositions pharmaceutiques ou cosmetiques comportant des phases lamellaires lipidiques hydratees
US4604376A (en) * 1982-04-21 1986-08-05 Research Corporation Enteric compounds and complexes
US4436746A (en) * 1982-09-30 1984-03-13 Ciba-Geigy Corporation Thromboxane synthetase inhibitory N-substituted-2-(1-imidazolyl)indoles
US4622219A (en) * 1983-06-17 1986-11-11 Haynes Duncan H Method of inducing local anesthesia using microdroplets of a general anesthetic
IL78930A0 (en) * 1985-07-29 1986-09-30 Abbott Lab Lyophilized emulsion compositions for parenteral administration
IL78929A0 (en) * 1985-07-29 1986-09-30 Abbott Lab Microemulsion compositions for parenteral administration

Also Published As

Publication number Publication date
ATE118169T1 (de) 1995-02-15
NO884391L (no) 1988-11-24
PT86913A (pt) 1989-03-30
NL990004I1 (nl) 1999-04-01
IE880600L (en) 1988-09-05
EP0282405A3 (en) 1989-01-04
FI894161A0 (fi) 1989-09-04
IL85607A0 (en) 1988-08-31
ES2070131T5 (es) 1998-10-01
NO1998012I1 (no) 1998-03-25
WO1988006443A1 (en) 1988-09-07
FI102724B (fi) 1999-02-15
IE67152B1 (en) 1996-03-06
EP0282405B1 (en) 1995-02-08
ES2070131T3 (es) 1995-06-01
CA1338701C (en) 1996-11-12
HK1007495A1 (en) 1999-04-16
DE3852961D1 (de) 1995-03-23
NO179995C (no) 1997-01-29
DK176010B1 (da) 2005-11-28
NO944071D0 (no) 1994-10-26
NO179995B (no) 1996-10-21
NZ223660A (en) 1990-11-27
AU622405B2 (en) 1992-04-09
EP0282405A2 (en) 1988-09-14
NO884391D0 (no) 1988-10-04
NO1998013I1 (no) 1998-03-25
PT86913B (pt) 1993-07-30
KR890700341A (ko) 1989-04-24
GR3015916T3 (en) 1995-07-31
DK98089A (da) 1989-03-01
NO180147B (no) 1996-11-18
FI102724B1 (fi) 1999-02-15
KR970002870B1 (ko) 1997-03-12
NO180147C (no) 1997-02-26
IL85607A (en) 1992-08-18
CN1044093C (zh) 1999-07-14
DE3852961T3 (de) 1998-12-24
AU1799088A (en) 1988-09-26
LU88684I2 (fr) 1996-04-29
NO944071L (no) 1988-11-24
DE3852961T2 (de) 1995-07-06
EP0282405B2 (en) 1998-07-22
CN88101864A (zh) 1988-09-28

Similar Documents

Publication Publication Date Title
DK98089D0 (da) Medikament-lipid-systemer med lav toxicitet
ATE119771T1 (de) Behandlung von beschädigtem knochenmark und dosierungseinheiten dafür.
DK0806941T3 (da) Liposomalt antibakterielt præparat med lav fasthed
HU9302496D0 (en) Method for producing anti-viral nucleoside combinations and one for preparing medical preparatives containing said compounds
BG101118A (en) Therapeutical compounds
DE3575927D1 (de) Purinderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitung.
NO307326B1 (no) Lipofile, oligosakkaride antibiotikasaltpreparater
ES2044843T3 (es) Uso de antibioticos de quinolona y naftiridina en la preparacion de medicamentos oftalmicos.
PH27446A (en) Compound with gastric acid inhibitory effect
SE8501532D0 (sv) Nya lekemedelskombinationer med synergistisk verkan och forfarande for deras framstellning
GR3004655T3 (da)
ATE71299T1 (de) Pharmazeutische zubereitung zur behandlung bakterieller infektionen.
ES2169117T3 (es) Uso de derivados de 2-aminopurina en el tratamiento y profilaxis de la infeccion por el virus 7 del herpes humano.
IT1247093B (it) Derivati salini del gliceril fosforil mioinositolo ad attivita' terapeutica, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
EP0281092A3 (de) Cephalosporinderivate und Verfahren zu ihrer Herstellung
PT728001E (pt) Utilizacao de derivados de 2-amino-purina para o tratamento e profilaxia das infeccoes pelo virus de herpes humano.

Legal Events

Date Code Title Description
AGE Re-establishment of rights: approved
CTFF Application for supplementary protection certificate (spc) filed

Spc suppl protection certif: CA 2006 00014

Filing date: 20060524

Expiry date: 20100209

CTFG Supplementary protection certificate (spc) issued

Free format text: PRODUCT NAME: AMPHOTERICIN B, LIPID KOMPLEKS

Spc suppl protection certif: CA 2006 00014

Filing date: 20060524

PUP Patent expired